In this issue of JAMA Internal Medicine, the article by Judge-Golden et al1 provides further evidence that dispensing a larger supply of contraception is cost-effective. This economic decision model explored the financial implications for the Veteran Affairs (VA) health care system of offering beneficiaries 12 months of oral contraceptive pills (OCPs) in a single prescription. Across a range of sensitivity analyses, the authors found that the 12-month dispensing option was cost saving to the VA compared with the standard 3-month dispensing option, largely owing to the reduction in unintended pregnancy.